Idorsia Company

Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
Technology: Small Molecules
Industry: BioTech
Headquarters: Allschwil
Founded Date: 2017
Employees Number: 501-1000
Total Funding: $1.4B

Visit Website
Register and Claim Ownership